Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease

Neurogastroenterology and Motility

Volumn 25, Issue 9, 2013, Pages

  Walter, S A ^a   Jones, M P ^b   Talley, N J ^c   Kjellstrom L ^d,e   Nyhlin, H ^d   Andreasson, A N ^d   Agreus L ^d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Sabbatsberg Hospital   (Sweden)

Author keywords

Abdominal pain; Anxiety; Depression; Endoscopy; Irritable Bowel Syndrome; Quality of life

Indexed keywords

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; COLON DISEASE; COLONOSCOPY; DEPRESSION; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ROME II MODULAR QUESTIONNAIRE; SHORT FORM 36; ANXIETY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

ABDOMINAL PAIN; ADULT; AGED; ANXIETY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES;

EID: 84881311518     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12155     Document Type: Article

References (63)

1. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988; 32: 173-83.
2. Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153: 2474-80.
3. Rief W, Hessel A, Braehler E. Somatization symptoms and hypochondriacal features in the general population. Psychosom Med 2001; 63: 595-602.
4. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80.
5. Locke GR 3rd, Weaver AL, Melton LJ 3rd, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004; 99: 350-7.
6. Svedlund J, Sjodin I, Dotevall G, Gillberg R. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol 1985; 20: 595-601.
7. Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987; 28: 1307-18.
8. Blanchard EB, Scharff L, Schwarz SP, Suls JM, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990; 28: 401-5.
9. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-56.
10. Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. Am J Med 1992; 92: 26S-30S.
11. Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry 1994; 151: 64-70.
12. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 2001; 62 (Suppl. 8): 38-45; discussion 6-7.
13. Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I, Stein MB. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 2006; 166: 2109-16.
14. Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Lowe B. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res 2008; 64: 605-12.
15. Karling P, Danielsson A, Adolfsson R, Norrback KF. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol Motil 2007; 19: 896-904.
16. Thijssen AY, Jonkers DM, Leue C et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol 2010; 44: e236-41.
17. Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007; 69: 860-3.
18. Drossman DA, Whitehead WE, Toner BB et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000; 95: 974-80.
19. Drossman DA, McKee DC, Sandler RS et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
20. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol 2001; 96: 1072-9.
21. Weinryb RM, Osterberg E, Blomquist L, Hultcrantz R, Krakau I, Asberg M. Psychological factors in irritable bowel syndrome: a population-based study of patients, non-patients and controls. Scand J Gastroenterol 2003; 38: 503-10.
22. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12: 453-66.
23. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-96.
24. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20(Suppl. 7): 31-9.
25. Enck P, Kowalski A, Martens U, Klosterhalfen S. Internet-based assessment of bowel symptoms and quality of life. Eur J Gastroenterol Hepatol 2006; 18: 1263-9.
26. Simren M, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001; 36: 545-52.
27. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654-60.
28. Forsberg AM, Kjellstrom L, Agreus L et al. Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scand J Gastroenterol 2012; 47: 184-90.
29. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-4.
30. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western Infants. Acta Paediatr 2009; 88: 229-38.
31. Agreus L, Svardsudd K, Nyren O, Tibblin G. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care 1993; 11: 252-62.
32. Drossman DA, Corazziari E, Talley J et al. ROME II. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Concencus, 2nd edn. VA, USA: Degnon Associates, 2000.
33. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
34. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
35. Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol 1999; 34: 993-1000.
36. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-4.
37. Sullivan BA, McKinnis R, Laufman LR. Quality of life in patients with metastatic colorectal cancer receiving chemotherapy: a randomized, double-blind trial comparing 5-FU versus 5-FU with leucovorin. Pharmacotherapy 1995; 15: 600-7.
38. Rome I. Rome II: a multinational consensus document on functional gastrointestinal disorders. Gut 1999; 45 (Suppl. 11): 1143-7.
39. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
40. Talley NJ, Zinsmeister AR, Melton LJ 3rd. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995; 142: 76-83.
41. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
42. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000; 35: 142-51.
43. Ebling B, Jurcic D, Gmajnic R, Vcev A, Bilic A, Pribic S. Anthropological, demographic and socioeconomic characteristics of irritable bowel syndrome. Coll Antropol 2011; 35: 513-21.
44. Olafsdottir LB, Gudjonsson H, Thjodleifsson B. Epidemiological study of functional bowel disorders in Iceland. Laeknabladid 2005; 91: 329-33.
45. Aro P, Talley NJ, Ronkainen J et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009; 137: 94-100.
46. Alexander JL, Dennerstein L, Kotz K, Richardson G. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology. Expert Rev Neurother 2007; 7 (Suppl. 11): S45-58.
47. Wittchen HU, Jacobi F, Rehm J et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-79.
48. Drossman DA, Li Z, Andruzzi E et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
49. Hessel A, Beutel M, Geyer M, Schumacher J, Brahler E. Prevalence of somatoform pain complaints in the German population. Psychosoc Med 2005; 2: Doc03.
50. Walter SA, Kjellstrom L, Talley NJ, Andreasson AN, Nyhlin H, Agreus L. Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study. Dig Dis Sci 2011; 56: 1444-51.
51. Suttor VP, Prott GM, Hansen RD, Kellow JE, Malcolm A. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum 2010; 53: 156-60.
52. Geeraerts B, van Oudenhove L, Vos R, Tack J. Influence of experimentally induced anxiety on rectal sensorimotor function in healthy humans. Neurogastroenterol Motil 2008; 20: 1227-33.
53. Gonlachanvit S, Rhee J, Sun WM, Chey WD. Effect of acute acoustic stress on anorectal function sensation in healthy human. Neurogastroenterol Motil 2005; 17: 222-8.
54. McColl E. Best practice in symptom assessment: a review. Gut 2004; 53 (Suppl. 4): iv49-54.
55. Bolger N, Davis A, Rafaeli E. Diary methods: capturing life as it is lived. Annu Rev Psychol 2003; 54: 579-616.
56. Stone AA, Broderick JE, Kaell AT. Single momentary assessments are not reliable outcomes for clinical trials. Contemp Clin Trials 2010; 31: 466-72.
57. Houtveen JH, Oei NY. Recall bias in reporting medically unexplained symptoms comes from semantic memory. J Psychosom Res 2007; 62: 277-82.
58. Fogarty SJ, Hemsley DR. Depression and the accessibility of memories. A longitudinal study. Br J Psychiatry 1983; 142: 232-7.
59. Ruiz-Caballero JA, Bermudez J. Neuroticism, mood, and retrieval of negative personal memories. J Gen Psychol 1995; 122: 29-35.
60. Naliboff BD. Choosing outcome variables: global assessment and diaries. Gastroenterology 2004; 126 (Suppl. 1): S129-34.
61. Posserud I, Svedlund J, Wallin J, Simren M. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease. J Psychosom Res 2009; 66: 399-405.
62. Frohlich C, Jacobi F, Wittchen HU. DSM-IV pain disorder in the general population. An exploration of the structure and threshold of medically unexplained pain symptoms. Eur Arch Psychiatry Clin Neurosci 2006; 256: 187-96.
63. Hauser W, Schmutzer G, Hinz A, Hilbert A, Brahler E. Prevalence of chronic pain in Germany: a representative survey of the general population. Schmerz 2013; 27: 46-55.